Blocking huntingtin oligomers from binding lipid membranes improves phenotype in a C. elegans model of Huntington's disease

被引：0
|
作者：
Siriwardhana, Chathuranga [1 ]
Legleiter, Justin A. [1 ]
机构：
[1] West Virginia Univ, Dept Chem, Morgantown, WV USA
来源：
BIOPHYSICAL JOURNAL | 2023年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
1650-Pos
引用
收藏
页码：338A / 339A
页数：2
相关论文
共 50 条
  • [31] Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson's disease
    Saewanee, Nada
    Praputpittaya, Theethawat
    Malaiwong, Nawaphat
    Chalorak, Pawanrat
    Meemon, Krai
    NEUROSCIENCE RESEARCH, 2021, 162 : 13 - 21
  • [32] C. elegans as a Genetic Model System to Identify Parkinson's Disease-Associated Therapeutic Targets
    Vistbakka, Julia
    VanDuyn, Natalia
    Wong, Garry
    Nass, Richard
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (08) : 957 - 964
  • [33] Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease
    Garcia-Moreno, Calahorra J.
    Porta de la Riva, Montserrat
    Martinez-Lara, Esther
    Siles, Eva
    Canuelo, Ana
    NEUROBIOLOGY OF AGING, 2019, 82 : 60 - 68
  • [34] MosSCI and CRISPR C. elegans models of LRRK2 related Parkinson's disease fail to produce the expected phenotype
    Pereira, C.
    Sequeiros, J.
    Gassmann, R.
    Alonso, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 296 - 296
  • [35] Mutant Huntingtin and Glycogen Synthase Kinase 3-β Accumulate in Neuronal Lipid Rafts of a Presymptomatic Knock-In Mouse Model of Huntington's Disease
    Valencia, Antonio
    Reeves, Patrick B.
    Sapp, Ellen
    Li, Xueyi
    Alexander, Jonathan
    Kegel, Kimberly B.
    Chase, Kathryn
    Aronin, Neil
    DiFiglia, Marian
    JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (01) : 179 - 190
  • [36] Effect of Various Classes of Pesticides on Expression of Stress Genes in Transgenic C. elegans Model of Parkinson's Disease
    Jadiya, Pooja
    Mir, Snober S.
    Nazir, Aamir
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (08) : 1001 - 1005
  • [37] In silico and In vivo Evaluation of Oxidative Stress Inhibitors Against Parkinson's Disease using the C. elegans Model
    Hanumanthappa, Pradeep
    Ashok, Arpitha
    Prakash, Inderjit
    Priya, Carmel, I
    Zinzala, Julie
    Marigowda, Vidya V.
    Sosalegowda, Aparna H.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2020, 23 (08) : 814 - 826
  • [38] alphaS1-Casein administration to a C. elegans model of Alzheimer's disease through proteoliposome delivery
    Carrotta, Rita
    Paterna, Angela
    Santonicola, Pamela
    Di Prima, Giulia
    Rao, Estella
    Raccosta, Samuele
    Zampi, Giuseppina
    Moran, Oscar
    Manno, Mauro
    Di Schiavi, Elia
    Librizzi, Fabio
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2023, 52 (SUPPL 1): : S174 - S174
  • [39] The absence of the aryl hydrocarbon receptor in the R6/1 transgenic mouse model of Huntington?s disease improves the neurological phenotype
    Angeles-Lopez, Quetzalli D.
    Garcia-Lara, Lucia
    Aguirre-Pineda, Nicolas
    Castaneda-Arellano, Rolando
    Elizondo-Azuela, Guillermo
    Perez-Severiano, Francisca
    Segovia, Jose
    BEHAVIOURAL BRAIN RESEARCH, 2021, 408
  • [40] Isolation of inclusion bodies and filaments from a mouse model of Huntington's disease reveals that proteasome inhibition depends on the degree of huntingtin aggregation
    Valera, AG
    Díaz-Hernández, M
    Hernández, F
    Ortega, Z
    Lucas, JJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
12345